Related Practice Life Sciences & Pharma The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies 01262022170133
Published Articles Life Sciences & Pharma Biopharma predictions for 2026: thoughts from LEK Consulting’s Simon Middleton January 14, 2026
Executive Insights Life Sciences & Pharma China’s Life Sciences Sector in Transition: How Suppliers Can Thrive in the Next Chapter August 29, 2025
Executive Insights Life Sciences & Pharma From Bench to Bedside: Academic-to-Industry Translation in European Biopharma June 25, 2025
Article MedTech Hospital Priorities 2025 China Edition: Key Findings for Medtech and Pharma Companies June 20, 2025
Executive Insights Healthcare The Race Is On: Winning Smart in the Intensifying GLP-1 Market in China May 15, 2025